Elfrida Hartveit Kvarstein

Elfrida Hartveit Kvarstein serves as an Adjunct Professor at the University of Oslo's Faculty of Medicine within the Adult Psychiatry Unit at Oslo University Hospital Ullevål. Her primary clinical and research focus centers on personality disorders, particularly borderline and avoidant personality disorders, with extensive work on mentalization-based treatment (MBT) approaches.

Her research spans multiple critical areas including therapeutic alliance dynamics, countertransference phenomena, alexithymia assessment, reflective functioning, and the economic burden of personality disorders. She has been instrumental in developing assessment tools like the Mentalization Breakdown Interview and conducting large-scale studies on personality disorder treatment outcomes. Her work frequently employs longitudinal and naturalistic study designs to understand treatment processes and outcomes in real-world clinical settings.

Analysis of her recent publications reveals a strong emphasis on transdiagnostic approaches to personality disorders, with particular attention to how factors like alexithymia, mentalization capacity, and somatic comorbidities influence treatment outcomes. Her research increasingly incorporates economic analyses of personality disorders, demonstrating the substantial societal costs associated with these conditions. The Extreme Challenges research project represents a major ongoing initiative examining patients with severe self-harm behaviors.

As a key member of the Norwegian Network for Personality Disorders, she has contributed to the field's development over three decades. Her methodological expertise includes psychometric validation studies, longitudinal observational research, and cost-effectiveness analyses within psychiatric care systems.

Her collaborative work extends across multiple Norwegian institutions and international partnerships, with frequent co-authorship with researchers like Geir Pedersen, Theresa Wilberg, and Benjamin Hummelen. She has made significant contributions to understanding how personality functioning changes during treatment and how therapeutic factors influence outcomes for patients with complex personality pathology.